Cargando…
HER2 Stabilizes EGFR and Itself by Altering Autophosphorylation Patterns in a Manner That Overcomes Regulatory Mechanisms and Promotes Proliferative and Transformation Signaling
One of the causes of breast cancer is overexpression of the human epidermal growth factor receptor 2 (HER2). Enhanced receptor autophosphorylation and resistance to activation-induced down regulation have been suggested as mechanisms for HER2-induced sustained signaling and cell transformation. Howe...
Autores principales: | Hartman, Zachary, Zhao, Hua, Agazie, Yehenew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538112/ https://www.ncbi.nlm.nih.gov/pubmed/23027125 http://dx.doi.org/10.1038/onc.2012.418 |
Ejemplares similares
-
Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine
Phosphatase SHP2 with Anti-Breast Cancer Cell Effects
por: Hartman, Zachary, et al.
Publicado: (2020) -
Autophosphorylation of the carboxyl‐terminal domain is not required for oncogenic transformation by lung‐cancer derived EGFR mutants
por: Cho, Jeonghee, et al.
Publicado: (2018) -
Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
por: Zhao, Hua, et al.
Publicado: (2015) -
SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021) -
Pyk2 suppresses contextual fear memory in an autophosphorylation-independent manner
por: Zheng, Jin, et al.
Publicado: (2021)